Hahn & Co. to award bonus shares to Namyang staff, retires $7.1 mn in shares
Seoul-based private equity firm Hahn & Co. will award employees of Namyang Dairy Products Co., a South Korean dairy product producer, 1.6 billio...
Seoul vows zero-tolerance measures against unfair stock trading
South Korea’s top financial regulators and its stock exchange operator will launch a joint task force to strengthen oversight of unlawful fina...
Celltrion secures $730 mn to buy biosimilar unit shares, pursue M&A
Celltrion Holdings Co. has secured 1 trillion won ($732 million) in fresh funding and plans to spend half of it this year to buy shares in its biosi...
S.Korea's stablecoin frenzy fuels stock rally despite regulatory uncertainty
A wave of speculative fervor surrounding won-based stablecoins is sweeping South Korea’s equity markets, with nearly half of the top 30 perfor...
KakaoBank rallies after winning Thai virtual banking license
Shares in KakaoBank Corp. soared as much as 17% to hit their highest level in nearly three years on Friday after the South Korean internet-only bank...
Miri Capital closes in on STIC Investments chairman’s stake
Miri Capital Management LLC has steadily raised its stake in STIC Investments Inc., narrowing the ownership gap with the firm’s founder and Ch...
Lee vows policy overhaul to spur dividend payouts
South Korean President Lee Jae-myung said on Wednesday that the government is preparing tax and regulatory reforms to spur dividend payouts as part ...
Korea signs definitive $19 bn Czech nuclear plant deal after twists and turns
South Korea has secured its most significant nuclear export deal in over a decade, as a consortium led by Korea Hydro & Nuclear Power (KHNP) cli...
NPS to lift stock holdings to 55% by 2030, raising risk appetite
The National Pension Service (NPS) plans to raise its equity allocation to about 55% of its assets by 2030 from 40.4% as of the end of February, Sou...
Celltrion shares rise after bonus issue announcement
Celltrion Inc., South Korea’s largest biosimilar developer, will issue bonus shares to bolster its stock performance, which has been in the do...
Europe looms large as K-beauty brands look to blue ocean; shares rise
South Korea’s beauty industry has been reaping decent gains from traditionally strong markets such as China and the US – the world&rsquo...
NPS gobbles up Korea’s top 4 financial holding stocks
South Korea’s largest institutional investor, the National Pension Service (NPS), remains a strong backer of the country’s top four fina...
Hong Kong to list world’s 1st Samsung single-stock leveraged ETF
A pair of leveraged exchange-traded funds tracking only Samsung Electronics Co. will make a debut on the stock exchange in Hong Kong next week, whic...
K-pop stocks surge as China set to loosen cultural ban after 9 years
Shares in South Korea’s leading entertainment companies are rallying amid growing signs that China will likely lift its longstanding ban on Ko...
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
South Korea nears Czech nuclear deal; Doosan, related stocks fly high
South Korea’s nuclear energy stocks surged this week as momentum builds around a landmark nuclear power project in the Czech Republic, with in...
South Korea’s renewed stock market darlings: Weapons makers
South Korea’s defense industry is once again capturing investor attention, as exports of tanks, armored vehicles and other weapons systems soa...
Celltrion expands footprint in Latin America with flagship oncology drugs
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
NPS pours $3.9 bn to buttress Korean stock market
South Korea’s National Pension Service, the country’s largest institutional investor, has come to the rescue of the domestic stock marke...
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
South Korean stocks, currency dive amid deeper US tariff turmoil
The South Korean stock market logged its biggest daily loss of more than 5% in eight months on Monday, joining its Asian peers bruised by panic sell...
LG Electronics set for early-May Indian stock market debut
LG Electronics Inc. is set to list its wholly owned subsidiary in India on the country's stock exchange in early May, aiming to raise up to $1.5 bil...
Korean entertainment stocks advance, unfazed by US tariff concerns
South Korean entertainment and gaming stocks climbed on Friday, defying a broader market drop as investors sought refuge in sectors seen as immune t...
K-pop exports boom as end of Chinese K-wave ban looms large
Exports of Korean popular music, or K-pop, have seen a significant surge in recent months, driven by increasing demand from China and Japan, accordi...
All listed stocks to be available for shorting in South Korea
South Korea will allow short selling of all listed stocks in the country as of Monday for the first time in five years, raising expectations of more...
Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
S.Korea’s NPS to double pension fund size by 2050, hike risky assets
South Korea’s National Pension Service (NPS) is projected to nearly double its fund size to 3,500 trillion won ($2.38 trillion) by 2050, follo...
Celltrion to cancel $140 mn in treasury shares, stock up
South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...
China stock funds outperform US funds in South Korea
Chinese stocks are attracting South Korean investors looking beyond Wall Street amid the downturn in US Big Tech stocks.South Korea’s equity f...
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
